Propeller Health adds spirometry through licensing deal with Italian device manufacturer MIR
The deal adds spirometers and spirometry data to Propeller's platform, expanding the size of the patient population the company targets.
FDA clears Propeller Health sensor for GSK Ellipta inhaler
Propeller and GlaxoSmithKline announced a joint development agreement less than a year ago.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Propeller Health closes Series C round, plans to add more respiratory meds to adherence platform
New investors included strategic investors SR One, the investment arm of GlaxoSmithKline, Hikma Ventures, part of Hikma Pharmaceuticals, and 3M Ventures.
In the future, medicines + digital experiences will bring more effective drugs
In the next few years new products that combine drugs with digital experiences will begin to appear and will likely be more effective than regular drugs, says Chris Hogg of Propeller Health, a speaker at the upcoming MedCity ENGAGE conference in San Diego.
Dignity Health ramps up use of Propeller Health for asthma
A recent study at Dignity Health revealed that patients who used the Propeller Health platform saw greater improvement in symptom- free days than patients receiving routine care. And adults who experienced uncontrolled asthma also saw improvements.
Boehringer Ingelheim backs commercialization of connected inhalers for COPD, asthma patients
Patients on Boehringer Ingelheim drugs for respiratory conditions have the option to enroll with certain health systems to get free access to inhalers embedded with Propeller Health sensors.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
These pharma and digital health collaborations are poised to transform clinical trials
Propeller Health added another big pharma partner with its GlaxoSmithKline research and development deal to produce sensors for the company's Ellipta dry powder inhaler to monitor COPD and asthma patients.
From J&J’s new health risk assessment product to Mass General’s telemedicine service: 5 must-read stories from MedCity News this week
Watch Friday's MedHeads and catch up on the top stories from the week including J&J improving user health to Mass General launching a telemedicine service.
FDA clears Propeller Health remote monitoring platform for GSK inhaler as beyond the pill trend grows
The clearance permits companies that use medications with GSK's Diskus dry powder inhaler for COPD patients to use Propeller's platform to better understand how COPD patients used their inhaler between appointments.
There’s a strong case to be made for simplifying what wearables do
Simplify, simplify, simplify. Henry Thoreau was more interested in removing the incumbrances of his life and building a cabin in the woods than getting his head around the health tracking market. But a Wired magazine article makes a good case for the need to stop building Swiss army knives of wearables that have a bunch […]
BioLabs Pegasus Park Cultivates Life Science Ecosystem
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
2015 means v3.0 for digital health and me
As the editor of MedCity News, I have given away a lot of business cards over the last 3 years. I have met entrepreneurs all over the country, learned about financing options from investors and talked with doctors about new ways of working with patients. I’ve listened to dozens of pitches and moderated panels about […]
Medication monitoring company for asthma, COPD attracts $14.5M
Propeller Health, which developed an FDA-cleared sensor to track where and when patients with asthma, COPD and other respiratory diseases use their inhalers and take medication related to their condition, has closed a Series B round to accelerate product development and ramp up sales and marketing. Safeguard Scientifics led the financing for the $14.5 million […]